SEARCH

SEARCH BY CITATION

References

  • 1
    Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95, 1336313383.
  • 2
    Cosseddu GM, Agrimi U, Pinto J & Schudel AA (2007) Advances in scrapie research. Rev Sci Techol 26, 657668.
  • 3
    Belay ED & Schonberger LB (2002) Variant Creutzfeldt–Jakob disease and bovine spongiform encephalopathy. Clin Lab Med 22, 849862.
  • 4
    Miller MW & Williams ES (2004) Chronic wasting disease of cervids. Curr Top Microbiol Immunol 284, 193214.
  • 5
    Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ & Alpers M (2006) Kuru in the 21st century – an acquired human prion disease with very long incubation periods. Lancet 367, 20682074.
  • 6
    Almer G, Hainfellner JA, Brucke T, Jellinger K, Kleinert R, Bayer G, Windl O, Kretzschmar HA, Hill A, Sidle K et al. (1999) Fatal familial insomnia: a new Austrian family. Brain 122, 516.
  • 7
    Westergard L, Christensen HM & Harris DA (2007) The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 1772, 629644.
  • 8
    Caughey B & Baron GS (2006) Prions and their partners in crime. Nature 443, 803810.
  • 9
    Watts JC & Westaway D (2007) The prion protein family: diversity, rivalry, and dysfunction. Biochim Biophys Acta 1772, 654672.
  • 10
    Zomosa-Signoret V, Arnaud JD, Fontes P, Alvarez-Martinez MT & Liautard JP (2008) Physiological role of the cellular prion protein. Vet Res 39, 9.
  • 11
    Bremer J, Baumann F, Tiberi C, Wessig C, Fischer H, Schwarz P, Steele AD, Toyka KV, Nave KA, Weis J et al. (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13, 310318.
  • 12
    Pasupuleti M, Roupe M, Rydengard V, Surewicz K, Surewicz WK, Chalupka A, Malmsten M, Sorensen OE & Schmidtchen A (2009) Antimicrobial activity of human prion protein is mediated by its N-terminal region. PLoS ONE 4, 73587359.
  • 13
    Lee KS, Raymond LD, Schoen B, Raymond GL, Kett L, Moore RA, Johnson LM, Kett L, Moore RA, Johnson LM et al. (2007) Hemin interactions and alterations of the subcellular localization of prion protein. J Biol Chem 282, 3652536533.
  • 14
    Tagliavini F, Forloni G, Colombo L, Rossi G, Girola L, Canciani B, Angeretti N, Giampaolo L, Peressini E, Awan T et al. (2000) Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro. J Mol Biol 300, 13091322.
  • 15
    Vogtherr M, Grimme S, Elshorst B, Jacobs DM, Fiebig K, Griesinger C & Zahn R (2003) Antimalarial drug quinacrine binds to C-terminal helix of cellular prion protein. J Med Chem 46, 35633564.
  • 16
    Hafner-Bratkovic I, Gaspersic J, Smid LM, Bresjanac M & Jerala R (2008) Curcumin binds to the α-helical intermediate and to the amyloid form of prion protein – a new mechanism for the inhibition of PrPSc accumulation. J Neurochem 104, 15531564.
  • 17
    Mok SWF, Thelen KM, Riemer C, Bamme T, Gultner S, Lutjohann D & Baier M (2006) Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun 348, 697702.
  • 18
    Frid P, Anisimov SV & Popovic N (2007) Congo red and protein aggregation in neurodegenerative diseases. Brain Res Rev 53, 135160.
  • 19
    Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S et al. (2009) HMDB: a knowledge base for the human metabolome. Nucleic Acids Res 37, D603D610.
  • 20
    Lakowicz JR (2006) Principles of Fluorescence Spectroscopy, 3rd edn. Springer, New York.
  • 21
    Mayer M & Meyer B (2001) Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. J Am Chem Soc 123, 61086117.
  • 22
    Christen B, Hornemann S, Damberger FF & Wuthrich K (2009) Prion protein NMR structure from Tammar wallaby (Macropus euginii) shows that the B2–A2 loop is modulated by long-range sequence effects. J Mol Biol 389, 833845.
  • 23
    Yang M, Xi X & Yang P (2008) Thermodynamic analysis of fluorescence enhancement and quenching theory equations. Front Chem Chin 3, 254261.
  • 24
    Matsunaga Y, Peretz D, Williamson A, Burton D, Mehlhorn I, Groth D, Cohen FE, Prusiner SB & Baldwin MA (2001) Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins 44, 110118.
  • 25
    Jackson GS, Murray I, Hosszu LLP, Gibbs N, Waltho JP, Clarke AR & Collinge J (2001) Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 98, 85318535.
  • 26
    Walter ED, Chattopadhyay M & Millhauser GL (2006) The affinity of copper binding to the prion protein octarepeat domain: evidence for negative cooperativity. Biochemistry 45, 1308313092.
  • 27
    Nicoll AJ, Trevitt CR, Tattum MH, Risse E, Quarterman E, Ibarra AA, Wright C, Jackson GS, Sessions RB, Farrow M et al. (2010) Pharmacological chaperone for the structured domain of human prion protein. Proc Natl Acad Sci USA 107, 1761017615.
  • 28
    Langella E, Impronta R, Crescenci O & Barone V (2006) Assesing the acid–base and conformational properties of histidine residues in human prion protein (125–228) by means of pKa calculations and molecular dynamics simulations. Protein Struct Funct Bioinform 64, 167177.
  • 29
    Lonsdale D (2006) A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. eCAM 3, 4959.
  • 30
    Gangolf M, Czerniecki J, Radermecker M, Detry O, Nisolle M, Jouan C, Martin D, Chantraine F, Lakaye B, Wins P et al. (2010) Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells. PLoS ONE 5, e13616.
  • 31
    Thom JY, Davis RE & Icke GC (1986) Protein binding of thiamine in human plasma. Int J Vitam Nutr Res 56, 189195.
  • 32
    Parkhomenko IM, Strokina AA, Pilipchuk SI, Stepanenko SP, Chekhovskaia LI & Donchenko GV (2010) Existence of two different active sites on thiamine binding protein in plasma membranes of synaptosomes. Ukr Biokhim Zh 82, 3441.
  • 33
    Ganapathy V, Smith SB & Prasad PD (2004) SLC19: the folate/thiamine transporter family. Pflugers Arch 447, 641646.
  • 34
    Tichopad A, Pfaffl MW & Didier A (2003) Tissue-specific expression pattern of bovine prion gene: quantification using real-time RT-PCR. Mol Cell Probe 17, 510.
  • 35
    Moudjou M, Frobert Y, Grassi J & La Bonnardiere C (2001) Cellular prion protein status in sheep: tissue-specific biochemical signatures. J Gen Virol 82, 20172024.
  • 36
    Bjorndahl TC, Zhou GP, Liu XH, Perez-Pineiro R, Semenchenko V, Saleem F, Acharya S, Bujold A, Sobsey C & Wishart DS (2011) Detailed biophysical characterization of the acid-induced PrPC to PrPΒ conversion process. Biochemistry 50, 11621173.
  • 37
    Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J & Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277293.
  • 38
    Johnson BA (2004) Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol (NY) 278, 313352.
  • 39
    Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, Oldfield E, Markley JL & Sykes BD (1995) 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6, 135140.
  • 40
    Marion D, Driscoll PC, Kay LE, Wingfield PT, Bax A, Gronenborn AM & Clore GM (1989) Overcoming the overlap problem in the assignment of proton NMR spectra of larger proteins by use of three-dimensional heteronuclear proton–nitrogen-15 Hartmann–Hahn–multiple quantum coherence and nuclear Overhauser–multiple quantum coherence spectroscopy: application to interleukin 1.beta. Biochemistry 28, 61506156.
  • 41
    James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG, Kaneko K, Groth D, Mehlhorn I, Prusiner SB et al. (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci USA 94, 1008610091.
  • 42
    Goodsell DS, Morris GM & Olson AJ (1996) Automated docking of flexible ligands: applications of autodock. J Mol Recognit 9, 15.
  • 43
    Guha R, Howard MT, Hutchison GR, Murray-Rust P, Rzepa H, Steinbeck C, Wegner J & Willighagen EL (2006) The blue obelisks interoperability in chemical informatics. J Chem Inf Model 46, 991998.
  • 44
    Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS & Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30, 27852791.
  • 45
    Schwieters CD, Kuszewski JJ, Tjandra N & Clore GM (2003) The Xplor-NIH NMR molecular structure determination package. J Magn Res 160, 6674.